Bonnet, Sébastien <br/><br/>
Dehydroepiandrosterone reverses systemic vascular remodeling through the inhibition of the Akt/GSK3-/NFAT axis.  [electronic resource] 

 -  Circulation  Sep 2009 
 - 1231-40 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1524-4539 
<br/><br/><label>Standard No.: </label>10.1161/CIRCULATIONAHA.109.848911  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--pharmacology<br/>Angioplasty, Balloon--adverse effects<br/>Animals<br/>Apoptosis--drug effects<br/>Calcium--metabolism<br/>Carotid Arteries--cytology<br/>Carotid Artery Injuries--drug therapy<br/>Cell Division--drug effects<br/>Cell Membrane--metabolism<br/>Cells, Cultured<br/>Cytochromes c--metabolism<br/>Dehydroepiandrosterone--pharmacology<br/>Disease Models, Animal<br/>Glycogen Synthase Kinase 3--antagonists & inhibitors<br/>Glycogen Synthase Kinase 3 beta<br/>Hexokinase--metabolism<br/>Humans<br/>Kv1.5 Potassium Channel--metabolism<br/>Male<br/>Muscle, Smooth, Vascular--cytology<br/>NFATC Transcription Factors--metabolism<br/>Peripheral Vascular Diseases--drug therapy<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Rats<br/>Rats, Sprague-Dawley<br/>Voltage-Dependent Anion Channel 1--metabolism